Sublingual  	Sublingual  	 JJ	B-NP
immunotherapy  	immunotherapy  	 JJ	I-NP
mechanisms  	mechanisms  	 NNS	I-NP
of  	of  	 IN	O
action 	action 	 NN	O
:  	:  	 :	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
Th1  	Th1  	 CD	B-NP
response  	response  	 NN	I-NP
Specific  	Specific  	 JJ	I-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
SIT 	SIT 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
only  	only  	 JJ	O
treatment  	treatment  	 NN	O
able  	able  	 JJ	O
to  	to  	 TO	O
modify  	modify  	 VB	O
the  	the  	 DT	O
natural  	natural  	 JJ	O
history  	history  	 NN	O
of  	of  	 IN	O
allergic  	allergic  	 JJ	B-NP
subjects 	subjects 	 NNS	I-NP
.  	.  	 .	O
Several  	Several  	 JJ	O
aspects  	aspects  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
immunopathological  	immunopathological  	 JJ	B-NP
response  	response  	 NN	I-NP
modified  	modified  	 VBN	O
by  	by  	 IN	O
sublingual  	sublingual  	 JJ	B-NP
immunotherapy  	immunotherapy  	 NNS	I-NP
( 	( 	 -LRB-	O
SLIT 	SLIT 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
an  	an  	 DT	O
alternative  	alternative  	 JJ	O
route  	route  	 NN	O
of  	of  	 IN	O
administration  	administration  	 NN	B-NP
for  	for  	 IN	O
SIT 	SIT 	 NNP	O
,  	,  	 ,	O
have  	have  	 VBP	O
been  	been  	 VBN	O
investigated 	investigated 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
shift  	shift  	 NN	O
from  	from  	 IN	O
Th2-polarized  	Th2-polarized  	 CD	B-NP
immune  	immune  	 JJ	O
response  	response  	 NN	O
toward  	toward  	 IN	O
Th1-oriented  	Th1-oriented  	 CD	B-NP
pattern  	pattern  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
after  	after  	 IN	O
SLIT 	SLIT 	 NNP	O
.  	.  	 .	O
More  	More  	 RBR	O
recently 	recently 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
role  	role  	 NN	O
for  	for  	 IN	O
a  	a  	 DT	O
subpopulation  	subpopulation  	 NN	B-NP
of  	of  	 IN	I-NP
T  	T  	 NN	I-NP
cells  	cells  	 NNS	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
evidenced 	evidenced 	 VBN	O
:  	:  	 :	O
T  	T  	 NN	B-NP
regulatory  	regulatory  	 JJ	I-NP
cells  	cells  	 NNS	I-NP
( 	( 	 -LRB-	O
Treg 	Treg 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Allergic  	Allergic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
have  	have  	 VBP	O
a  	a  	 DT	O
defect  	defect  	 NN	O
of  	of  	 IN	O
Tregs 	Tregs 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
SLIT  	SLIT  	 NNP	O
should  	should  	 MD	O
be  	be  	 VB	O
able  	able  	 JJ	O
to  	to  	 TO	O
induce  	induce  	 VB	O
a  	a  	 DT	O
specific  	specific  	 JJ	O
Treg  	Treg  	 JJ	B-NP
response 	response 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
issue  	issue  	 NN	O
is  	is  	 VBZ	O
very  	very  	 RB	O
relevant  	relevant  	 JJ	O
as  	as  	 IN	O
the  	the  	 DT	O
Treg-dependent  	Treg-dependent  	 JJ	B-NP
cytokines 	cytokines 	 NN	I-NP
,  	,  	 ,	O
namely  	namely  	 RB	O
IL-10  	IL-10  	 CD	B-NP
and  	and  	 CC	O
TGF-beta 	TGF-beta 	 JJ	B-NP
,  	,  	 ,	O
are  	are  	 VBP	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
regulation  	regulation  	 NN	O
of  	of  	 IN	O
IgG  	IgG  	 JJ	O
and  	and  	 CC	O
IgA  	IgA  	 JJ	B-NP
antibodies  	antibodies  	 JJ	I-NP
production 	production 	 NN	I-NP
.  	.  	 .	O
Recent  	Recent  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
shows  	shows  	 NNS	I-NP
that  	that  	 IN	O
SLIT  	SLIT  	 NNP	O
is  	is  	 VBZ	O
also  	also  	 RB	O
able  	able  	 JJ	O
of  	of  	 IN	O
inducing  	inducing  	 VBG	O
a  	a  	 DT	O
Treg  	Treg  	 JJ	B-NP
response  	response  	 NN	I-NP
as  	as  	 IN	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
IL-10  	IL-10  	 CD	B-NP
production 	production 	 NN	I-NP
.  	.  	 .	O
IFNgamma  	IFNgamma  	 NNP	B-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
typical  	typical  	 JJ	O
Th1-dependent  	Th1-dependent  	 CD	B-NP
cytokine 	cytokine 	 NNS	I-NP
.  	.  	 .	O
SLIT  	SLIT  	 NNP	O
may  	may  	 MD	O
induce  	induce  	 VB	O
a  	a  	 DT	O
significantly  	significantly  	 RB	O
increased  	increased  	 VBN	B-NP
production  	production  	 NN	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
cytokine  	cytokine  	 NN	B-NP
and  	and  	 CC	O
it  	it  	 PRP	O
may  	may  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
an  	an  	 DT	O
early  	early  	 JJ	O
marker  	marker  	 NN	O
of  	of  	 IN	O
SLIT  	SLIT  	 NNP	O
response 	response 	 NN	O
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
also  	also  	 RB	O
SLIT  	SLIT  	 NNP	O
is  	is  	 VBZ	O
able  	able  	 JJ	O
of  	of  	 IN	O
exerting  	exerting  	 VBG	O
the  	the  	 DT	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
immune  	immune  	 JJ	O
response  	response  	 NN	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
subcutaneous  	subcutaneous  	 JJ	B-NP
route 	route 	 NN	I-NP
.  	.  	 .	O
